Sort
17,828 grants matching “crispr”
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity
$438,928Mireia Guerau-De-Arellano · Ohio State University · R01 · FY2017 · AI
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity
$438,928Mireia Guerau-De-Arellano · Ohio State University · R01 · FY2019 · AI
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity
$438,928Mireia Guerau-De-Arellano · Ohio State University · R01 · FY2016 · AI
Genetic basis of circadian rhythms and sleep disorders
$438,915Choogon Lee · Florida State University · R35 · FY2025 · GM
The Metabolic Regulation of Melanoma Metastasis
$438,803Sean J Morrison · Ut Southwestern Medical Center · U01 · FY2021 · CA
Multiplex modeling of ALS with barcoded human pluripotent stem cell lines
$438,800Hynek Wichterle · Columbia University Health Sciences · R21 · FY2019 · NS
REGULATION OF SKELETAL MUSCLE DEVELOPMENT AND MAINTENANCE BY PROTEIN O-GLUCOSYLTRANSFERASE 1 (POGLUT1)
$438,794Hamed Jafar-Nejad · Baylor College Of Medicine · R01 · FY2023 · AR
Mechanisms of liver metastasis and associated resistance to immunotherapy
$438,730Benjamin Izar · Columbia University Health Sciences · R37 · FY2022 · CA
Role of Pacs2 in central nervous system myelination
$438,625Yungki Park · State University Of New York At Buffalo · R21 · FY2021 · NS
Systematic discovery of critical oligodendrocyte transcription factors by a CRISPRi screen
$438,625Yungki Park · State University Of New York At Buffalo · R21 · FY2020 · NS
Mechanism of P73-dependent Tumor Suppression
$438,596Xinbin Chen · University Of California At Davis · R01 · FY2019 · CA
Core F: Induced Pluripotent Stem Cell Core
$438,540Mathew Mark Blurton-Jones · University Of California-Irvine · P30 · FY2023 · AG
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
$438,499Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2020 · CA
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
$438,499Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2017 · CA
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
$438,499Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Towards systematic analysis of cardiac voltage-gated sodium channel beta subunit function
$438,487Christopher A Ahern · University Of Iowa · R33 · FY2025 · HL
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$438,385Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Defining the role of CD38 and its potential as a therapeutic target in SBMA
$438,365Heather L Montie · Philadelphia College Of Osteopathic Med · R01 · FY2025 · NS
Evolved RNA Recognition Motifs for Therapeutic and Gene EditingApplications
$438,000Brian Richard McNaughton · Delaware State University · R15 · FY2022 · GM
Deregulation of long noncoding RNAs in cancer
$437,907Nadya M Dimitrova · Yale University · R01 · FY2022 · CA
O-glycosylation of cysteine-rich modules
$437,900Robert S. Haltiwanger · University Of Georgia · R35 · FY2025 · GM
O-glycosylation of cysteine-rich modules
$437,900Robert S. Haltiwanger · University Of Georgia · R35 · FY2024 · GM
O-glycosylation of cysteine-rich modules
$437,900Robert S. Haltiwanger · University Of Georgia · R35 · FY2023 · GM
Improvement of CRISPR-Cas9 specificity through allosteric modulation
$437,864Jin Liu · University Of North Texas Hlth Sci Ctr · R15 · FY2019 · HL
Project 3: Demethylation of HPV-associated head and neck cancer to trigger APOBEC synthetic lethality and enhance immune response
$437,838Karen S Anderson · Yale University · P50 · FY2023 · DE